Curium can't buy radiopharmacy institute IRAB, Spanish antitrust watchdog says
MLex Summary: Curium Pharma may not acquire the Barcelona Institute of Applied Radiopharmacy, or IRAB, the Spanish antitrust enforcer said on Monday. The agency cited "insurmountable competition risks" in the markets...To view the full article, register now.
Already a subscriber? Click here to view full article